|
Dr. Tobia started Dynamis Therapeutics in May, 1997. To date, she has successfully raised over $9 million in equity financing, licensing fees, and government grants.. In 1997, because of her extensive experience as founder and manager of start-up companies, Dr. Tobia was asked by Fox Chase Cancer Center to form a company around its science. At the time, she was managing partner of QED Technologies, which started and administered virtual companies for venture capital firms. While at QED, Dr. Tobia was acting president of Arcturus Pharmaceutical Co., a dermatology company founded by three Harvard dermatologists and funded by several Boston venture capitalists. Before starting QED with her partners, she was senior vice president and general counsel and founder of British Technology Group, USA (BTG), one of the world's leading technology transfer and licensing companies, as well as managing director of its parent company, BTG plc, a United Kingdom-based company. Prior to that she was counsel to the president of the Bristol Myers Institute for Medical Research, where she structured strategic alliances with biotech companies and academic institutions. She started her career as a post-doctoral fellow at Rockefeller University, where she was an American Cancer Society Fellow, and then earned her law degree from Rutgers University, Newark, NJ. | 